Cochrane Collaboration CAM Field: Resource for Research

科克伦协作网是一个国际性的、非盈利性的独立组织，致力于 改善世界人口的保健，为此准备、维持和促进 系统评价CAM领域是科克伦协作中的指定小组，重点关注 促进对补充和替代医学进行科克伦系统评价 治疗CAM领域是基于内，并由中心的中西医结合在 马里兰州的大学，因为它一直以来成立于1996年，在布赖恩伯曼，共同领导下， CAM领域的创始人和召集人。 在过去的四年中，CAM领域一直通过NCCAM的R24赠款得到支持。凸轮 外地利用R24资金，通过协调 编写高质量的CAM系统评价，改进CAM系统的研究方法 开展审查，开发CAM RCT的专业数据库，并广泛传播信息 向CAM研究人员介绍系统评价、循证CAM和科克伦合作组织， 从业人员、普通公众和政策制定者。然而，许多问题仍有待回答 关于CAM疗法的有效性和安全性， 严格收集、评估和传播CAM中的高质量信息。 为了扩大CAM领域作为研究资源的范围，制定了以下四个具体目标 对于我们的R24基金的提议：1）增加高质量系统评价的数量， CAM; 2）加大对科克伦CAM领域的推广; 3）完善和增加 CAM干预措施的随机对照试验;以及4）确保有效和高效的沟通 CAM领域成员与科克伦协作网内其他实体成员之间的沟通。 由于在美国和全球范围内对CAM疗法的兴趣和利用率只会增加，因此系统性综述 将继续是必不可少的临床医生和病人，因为他们寻求使知情，循证健康 护理决策。自成立以来，CAM领域进行了有价值的研究， 评论，已成为全球医学界的研究资源，并已成为 在国际科克伦协作网中担任重要的管理角色。CAM的生产率 由于研究基础设施和全球网络，该领域在未来几年只会增加 在过去的四年里，

The Cochrane Collaboration is an international, nonprofit, and independent organization dedicated to improving health care for the world's population by preparing, maintaining and promoting the accessibility of systematic reviews. The CAM Field is the designated group within the Cochrane Collaboration focused on facilitating the conduct of Cochrane systematic reviews of complementary and alternative medicine therapies. The CAM Field is based within and sponsored by the Center for Integrative Medicine at the University of Maryland, as it has been since inception in 1996, under the leadership of Brian Berman, co- founder and Convener of the CAM Field. Over the past four years the CAM Field has been supported through an R24 grant from NCCAM. The CAM Field has used the R24 funding to significantly further the priorities and goals of NCCAM by coordinating the preparation of high quality systematic reviews of CAM, improving research methods for CAM systematic review conduct, developing a specialized database of CAM RCTs, and widely disseminating information about systematic reviews, evidence-based CAM, and the Cochrane Collaboration, to CAM researchers, practitioners, the lay public, and policy-makers. However, many questions still remain to be answered regarding the effectiveness and safety of CAM therapies and much remains to be accomplished in the rigorous collection, evaluation, and dissemination of high quality information in CAM. To expand the CAM Field as a resource for research, the following four specific aims have been developed for this proposedrenewal of our R24 funding: 1) Increase the number of high quality systematic reviews in CAM; 2) Increase promotion of the Cochrane CAM Field; 3) Improve and increase the database of randomized controlledtrials of CAM interventions; and 4) Ensure effective and efficient communication between CAM Field members and members of other entities within the Cochrane Collaboration. As interest in and utilization of CAM therapies is only increasing in the US and worldwide, systematic reviews will continue to be essential to clinicians and patients as they seek to make informed, evidence-based health care decisions. Since its inception, the CAM Field has conducted valuable research related to systematic reviews, has served as a research resource for the worldwide medical community, and has served an important administrative role within the international Cochrane Collaboration. The productivity of the CAM Field will only increase in the coming years, due to the research infrastructure and worldwide network developed within it over the previous four years.